About: Extraordinary response to erlotinib therapy in a patient with lung adenocarcinoma exhibiting KRAS mutation and EGFR amplification

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Extraordinary response to erlotinib therapy in a patient with lung adenocarcinoma exhibiting KRAS mutation and EGFR amplification Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
rdfs:seeAlso	http://cgp.iiarjournals.org/content/8/3/135.full.pdf+html
Description	Authors presented a case report of male patient suffering with advanced lung adenocarcinoma exhibiting mutioned genetic abnormalities having got more than 3 years duration of remission on erlotinib therapy. Authors presented a case report of male patient suffering with advanced lung adenocarcinoma exhibiting mutioned genetic abnormalities having got more than 3 years duration of remission on erlotinib therapy. (en)
Title	Extraordinary response to erlotinib therapy in a patient with lung adenocarcinoma exhibiting KRAS mutation and EGFR amplification Extraordinary response to erlotinib therapy in a patient with lung adenocarcinoma exhibiting KRAS mutation and EGFR amplification (en)
skos:prefLabel	Extraordinary response to erlotinib therapy in a patient with lung adenocarcinoma exhibiting KRAS mutation and EGFR amplification Extraordinary response to erlotinib therapy in a patient with lung adenocarcinoma exhibiting KRAS mutation and EGFR amplification (en)
skos:notation	RIV/00669806:_____/11:10108620!RIV12-MZ0-00669806
http://linked.open...avai/riv/aktivita	N O P
http://linked.open...avai/riv/aktivity	N, O, P(NR9087)
http://linked.open...iv/cisloPeriodika	3
http://linked.open...vai/riv/dodaniDat	2012
http://linked.open...aciTvurceVysledku	Grossmann, Petr Pešek, Miloš Říčař, Jan
http://linked.open.../riv/druhVysledku	J - Článek v odborném periodiku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Fakultní nemocnice Plzeň
http://linked.open...dnocenehoVysledku	199117
http://linked.open...ai/riv/idVysledku	RIV/00669806:_____/11:10108620
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	EGFR amplification; KRAS mutation; erlotinib; adenocarcinoma; NSCLC (en)
http://linked.open.../riv/klicoveSlovo	KRAS mutation EGFR amplification adenocarcinoma NSCLC erlotinib
http://linked.open...odStatuVydavatele	GR - Řecká republika
http://linked.open...ontrolniKodProRIV	[0CEC494EC052]
http://linked.open...i/riv/nazevZdroje	Cancer Genomics and Proteomics
http://linked.open...in/vavai/riv/obor	FC
http://linked.open...ichTvurcuVysledku	3 (xsd:int)
http://linked.open...cetTvurcuVysledku	7 (xsd:int)
http://linked.open...vavai/riv/projekt	Use of molecular predictors for optimum selection of targeted therapy of non-small cell lung cancer
http://linked.open...UplatneniVysledku	2011
http://linked.open...v/svazekPeriodika	8
http://linked.open...iv/tvurceVysledku	Benešová, Lucie Grossmann, Petr Krejčí, Jana Minárik, Marek Pešek, Miloš Krejčí, M. Říčař, Jan
http://linked.open...ain/vavai/riv/wos	000290634700003
issn	1109-6535
number of pages	4 (xsd:int)

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 47 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software